1. Home
  2. MYFW vs CCCC Comparison

MYFW vs CCCC Comparison

Compare MYFW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

SELL

Current Price

$29.52

Market Cap

312.1M

Sector

Finance

ML Signal

SELL

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

SELL

Current Price

$2.77

Market Cap

350.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MYFW
CCCC
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
350.6M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
MYFW
CCCC
Price
$29.52
$2.77
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
★ $32.67
$12.86
AVG Volume (30 Days)
31.1K
★ 2.3M
Earning Date
10-22-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.02
16.45
EPS
★ 1.20
N/A
Revenue
★ $96,914,000.00
$35,947,000.00
Revenue This Year
$12.79
N/A
Revenue Next Year
$7.98
N/A
P/E Ratio
$24.55
★ N/A
Revenue Growth
★ 7.60
1.02
52 Week Low
$22.00
$1.69
52 Week High
$34.36
$5.17

Technical Indicators

Market Signals
Indicator
MYFW
CCCC
Relative Strength Index (RSI) 39.60 38.91
Support Level $27.71 $2.41
Resistance Level $30.00 $3.91
Average True Range (ATR) 0.58 0.21
MACD -0.04 -0.01
Stochastic Oscillator 34.78 22.44

Price Performance

Historical Comparison
MYFW
CCCC

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: